c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism (original) (raw)

Nature volume 458, pages 762–765 (2009)Cite this article

Abstract

Altered glucose metabolism in cancer cells is termed the Warburg effect, which describes the propensity of most cancer cells to take up glucose avidly and convert it primarily to lactate, despite available oxygen1,2. Notwithstanding the renewed interest in the Warburg effect, cancer cells also depend on continued mitochondrial function for metabolism, specifically glutaminolysis that catabolizes glutamine to generate ATP and lactate3. Glutamine, which is highly transported into proliferating cells4,5, is a major source of energy and nitrogen for biosynthesis, and a carbon substrate for anabolic processes in cancer cells, but the regulation of glutamine metabolism is not well understood1,6. Here we report that the c-Myc (hereafter referred to as Myc) oncogenic transcription factor, which is known to regulate microRNAs7,8 and stimulate cell proliferation9, transcriptionally represses miR-23a and miR-23b, resulting in greater expression of their target protein, mitochondrial glutaminase, in human P-493 B lymphoma cells and PC3 prostate cancer cells. This leads to upregulation of glutamine catabolism10. Glutaminase converts glutamine to glutamate, which is further catabolized through the tricarboxylic acid cycle for the production of ATP or serves as substrate for glutathione synthesis11. The unique means by which Myc regulates glutaminase uncovers a previously unsuspected link between Myc regulation of miRNAs, glutamine metabolism, and energy and reactive oxygen species homeostasis.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Deberardinis, R. J., Sayed, N., Ditsworth, D. & Thompson, C. B. Brick by brick: metabolism and tumor cell growth. Curr. Opin. Genet. Dev. 18, 54–61 (2008)
    Article CAS Google Scholar
  2. Kroemer, G. & Pouyssegur, J. Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell 13, 472–482 (2008)
    Article CAS Google Scholar
  3. DeBerardinis, R. J. et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl Acad. Sci. USA 104, 19345–19350 (2007)
    Article ADS CAS Google Scholar
  4. Reitzer, L. J., Wice, B. M. & Kennell, D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J. Biol. Chem. 254, 2669–2676 (1979)
    CAS PubMed Google Scholar
  5. Gallagher, F. A., Kettunen, M. I., Day, S. E., Lerche, M. & Brindle, K. M. 13C MR spectroscopy measurements of glutaminase activity in human hepatocellular carcinoma cells using hyperpolarized 13C-labeled glutamine. Magn. Reson. Med. 60, 253–257 (2008)
    Article CAS Google Scholar
  6. Curthoys, N. P. & Watford, M. Regulation of glutaminase activity and glutamine metabolism. Annu. Rev. Nutr. 15, 133–159 (1995)
    Article CAS Google Scholar
  7. Chang, T. C. et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nature Genet. 40, 43–50 (2008)
    Article CAS Google Scholar
  8. O’Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V. & Mendell, J. T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839–843 (2005)
    Article ADS Google Scholar
  9. Eilers, M. & Eisenman, R. N. Myc’s broad reach. Genes Dev. 22, 2755–2766 (2008)
    Article CAS Google Scholar
  10. Kita, K., Suzuki, T. & Ochi, T. Down-regulation of glutaminase C in human hepatocarcinoma cell by diphenylarsinic acid, a degradation product of chemical warfare agents. Toxicol. Appl. Pharmacol. 220, 262–270 (2007)
    Article CAS Google Scholar
  11. Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R. & Lazebnik, Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J. Cell Biol. 178, 93–105 (2007)
    Article CAS Google Scholar
  12. Li, F. et al. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol. Cell. Biol. 25, 6225–6234 (2005)
    Article CAS Google Scholar
  13. Schuhmacher, M. et al. Control of cell growth by c-Myc in the absence of cell division. Curr. Biol. 9, 1255–1258 (1999)
    Article CAS Google Scholar
  14. Lombardi, L., Newcomb, E. W. & Dalla-Favera, R. Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell 49, 161–170 (1987)
    Article CAS Google Scholar
  15. Gurel, B. et al. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. Mod. Pathol. 21, 1156–1167 (2008)
    Article CAS Google Scholar
  16. Perez-Gomez, C. et al. Co-expression of glutaminase K and L isoenzymes in human tumour cells. Biochem. J. 386, 535–542 (2005)
    Article CAS Google Scholar
  17. Turner, A. & McGivan, J. D. Glutaminase isoform expression in cell lines derived from human colorectal adenomas and carcinomas. Biochem. J. 370, 403–408 (2003)
    Article CAS Google Scholar
  18. Berns, K., Hijmans, E. M., Koh, E., Daley, G. Q. & Bernards, R. A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts. Oncogene 19, 3330–3334 (2000)
    Article CAS Google Scholar
  19. Nikiforov, M. A. et al. Complementation of Myc-dependent cell proliferation by cDNA expression library screening. Oncogene 19, 4828–4831 (2000)
    Article CAS Google Scholar
  20. Lora, J. et al. Antisense glutaminase inhibition decreases glutathione antioxidant capacity and increases apoptosis in Ehrlich ascitic tumour cells. Eur. J. Biochem. 271, 4298–4306 (2004)
    Article CAS Google Scholar
  21. Matsuno, T., Satoh, T. & Suzuki, H. Prominent glutamine oxidation activity in mitochondria of avian transplantable hepatoma induced by MC-29 virus. J. Cell. Physiol. 128, 397–401 (1986)
    Article CAS Google Scholar
  22. Porkka, K. P. et al. MicroRNA expression profiling in prostate cancer. Cancer Res. 67, 6130–6135 (2007)
    Article CAS Google Scholar
  23. Landgraf, P. et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401–1414 (2007)
    Article CAS Google Scholar
  24. Bode, B. P. Recent molecular advances in mammalian glutamine transport. J. Nutr. 131, 2475S–2485S (2001)
    Article CAS Google Scholar
  25. Lobo, C. et al. Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells. Biochem. J. 348, 257–261 (2000)
    Article CAS Google Scholar
  26. Rabilloud, T. et al. The mitochondrial antioxidant defence system and its response to oxidative stress. Proteomics 1, 1105–1110 (2001)
    Article CAS Google Scholar
  27. Anderson, T. J. et al. Discovering robust protein biomarkers for disease from relative expression reversals in 2-D DIGE data. Proteomics 7, 1197–1207 (2007)
    Article CAS Google Scholar
  28. Kersey, P. J. et al. The International Protein Index: an integrated database for proteomics experiments. Proteomics 4, 1985–1988 (2004)
    Article CAS Google Scholar
  29. Yates, J. R., Eng, J. K., McCormack, A. L. & Schieltz, D. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal. Chem. 67, 1426–1436 (1995)
    Article CAS Google Scholar
  30. Gao, P. et al. HIF-dependent antitumorigenic effect of antioxidants in vivo . Cancer Cell 12, 230–238 (2007)
    Article CAS Google Scholar

Download references

Acknowledgements

The authors want to thank L. Blosser and A. Tam for their help in flow cytometry analysis, and H. Y. Zhang for her help with statistical analysis. This work was partially supported by NIH Awards NHLBI NO1-HV-28180, NCI R01CA051497, NCI R01CA57341, NCI R01CA120185, NCI P50CA58236, Rita Allen Foundation, Leukemia and Lymphoma Society, and Sol Goldman Center for Pancreatic Cancer Research.

Author Contributions P.G., K.K., T.O., A.M.D., J.E.V., J.T.M. and C.V.D. designed experiments. P.G., I.T., T.-C.C., Y.-S.L. and K.I.Z. performed experiments. K.K. and T.O. provided reagents. P.G. and C.V.D. wrote the paper. All authors discussed the results and commented on the manuscript.

Author information

Authors and Affiliations

  1. Division of Hematology, Department of Medicine,,
    Ping Gao, Karen I. Zeller & Chi V. Dang
  2. Division of Cardiology, Department of Medicine,,
    Irina Tchernyshyov & Jennifer E. Van Eyk
  3. McKusick-Nathans Institute of Genetic Medicine,,
    Tsung-Cheng Chang, Yun-Sil Lee, Joshua T. Mendell & Chi V. Dang
  4. Departments of Pediatrics and,,
    Joshua T. Mendell
  5. Molecular Biology and Genetics,,
    Joshua T. Mendell & Chi V. Dang
  6. Departments of Pathology,,
    Angelo M. De Marzo & Chi V. Dang
  7. Oncology,,
    Angelo M. De Marzo & Chi V. Dang
  8. Urology,,
    Angelo M. De Marzo
  9. Biological Chemistry and,,
    Jennifer E. Van Eyk
  10. Cell Biology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA ,
    Chi V. Dang
  11. Laboratory of Toxicology, Faculty of Pharmaceutical Sciences, Teikyo University, Sagamiko, Kanagawa 229-0195, Japan ,
    Kayoko Kita & Takafumi Ochi

Authors

  1. Ping Gao
    You can also search for this author inPubMed Google Scholar
  2. Irina Tchernyshyov
    You can also search for this author inPubMed Google Scholar
  3. Tsung-Cheng Chang
    You can also search for this author inPubMed Google Scholar
  4. Yun-Sil Lee
    You can also search for this author inPubMed Google Scholar
  5. Kayoko Kita
    You can also search for this author inPubMed Google Scholar
  6. Takafumi Ochi
    You can also search for this author inPubMed Google Scholar
  7. Karen I. Zeller
    You can also search for this author inPubMed Google Scholar
  8. Angelo M. De Marzo
    You can also search for this author inPubMed Google Scholar
  9. Jennifer E. Van Eyk
    You can also search for this author inPubMed Google Scholar
  10. Joshua T. Mendell
    You can also search for this author inPubMed Google Scholar
  11. Chi V. Dang
    You can also search for this author inPubMed Google Scholar

Corresponding authors

Correspondence toPing Gao or Chi V. Dang.

Supplementary information

Supplementary Information

This file contains Supplementary Figures S1-S10 with Legends and Supplementary Tables S1-S2 (PDF 410 kb)

PowerPoint slides

Rights and permissions

About this article

Cite this article

Gao, P., Tchernyshyov, I., Chang, TC. et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.Nature 458, 762–765 (2009). https://doi.org/10.1038/nature07823

Download citation

This article is cited by

Editorial Summary

c-Myc is an oncogene involved in many forms of cancer. Proteomic analysis of human P-493 B lymphoma cells and PC3 prostate cancer cells shows that c-Myc regulates the microRNAs miR-23a and miR-23b to increase the expression of the mitochondrial enzyme glutaminase. This leads to enhanced glutamine metabolism and contributes to the metabolic changes in Myc-driven cancers.